DR. JAMES HARRISON RAYBOURN M.D. NPI 1871736595

NPI Details

DR. James Harrison Raybourn, M.D. is an urology in Greenwood, IN with 17 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. DR. James Harrison Raybourn, M.D. NPI is 1871736595. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: INDIANA UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:2009

The provider's business location address is:

679 E COUNTY LINE RD
GREENWOOD, IN
ZIP 46143-049
Phone: (317) 859-7222

The NPI 1871736595 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, denosumab, 1 mg (HCPCS:J0897)
• Bcg live intravesical instillation, 1 mg (HCPCS:J9030)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Bacterial colony count, urine (HCPCS:87086)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Bacterial urine culture (HCPCS:87088)
• Automated urinalysis test (HCPCS:81003)
• Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Testosterone (hormone) level, total (HCPCS:84403)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Cell examination of specimen, selective cellular enhancement technique (HCPCS:88112)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Sex hormone binding globulin (protein) level (HCPCS:84270)
• Psa (prostate specific antigen) measurement, free (HCPCS:84154)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Red blood cell concentration measurement (HCPCS:85014)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Measurement of total estradiol (hormone) (HCPCS:82670)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Detection test by nucleic acid for herpes simplex virus, amplified probe technique (HCPCS:87529)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Blood creatinine level (HCPCS:82565)
• Instillation of anti-cancer drug into bladder (HCPCS:51720)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Biopsy of prostate gland (HCPCS:55700)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Detection test by nucleic acid for cytomegalovirus (cmv), amplified probe technique (HCPCS:87496)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Detection test by nucleic acid for herpes virus-6, amplified probe technique (HCPCS:87532)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Prolactin (milk producing hormone) level (HCPCS:84146)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• Imaging of urinary tract following injection of a contrast agent (HCPCS:74420)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 4/10/2009 and was last updated on 1/19/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.